#AXSM
$AXSM Axsome Therapeutics: Q3 net product revenue up 52% to $259.7M (Q3 2026)
Hub: https://www.merlintrader.com/axsome-therapeutics-axsm-stock-hub-2026/?utm_source=bluesky&utm_medium=social&utm_campaign=flyer-q3-2026&utm_content=axsm

Not investment advice.
November 10, 2026 at 6:05 PM
Options money in #$AXSM: $1.3M calls vs $684K puts, $2.0M in all (65% calls).
Off-exchange (dark pool) shares, % of volume: Nov 11 476,720 (44.4%).
Dark pool trading Nov 11 hit 1.0x a normal day (5-day trend: fading).

Full story at the link.
#optionsflow #stocks #optionstrading #stockmarket
Axsome (AXSM) Technical Levels: Options Flow Mixed Between $145 and $170
AXSM at $149.24: support $145.42, resistance $169.96; the chart, options flow and dark pools are mixed.
globaltradersacademy.com
November 12, 2026 at 11:05 AM
96% of the #$AXSM options premium went into calls and 4% into puts.
Chart levels: last close $140.97, 20-day average $146.07, 50-day average $175.16, 20-day range $123.00 to $169.96.

Read the full article for the full details.
#optionsflow #stocks #optionstrading #fintwit
AXSM Technical Levels: Chart, Options Flow and Dark Pools Diverge at $141
AXSM at $140.97: support $123.00, resistance $146.07; the chart, options flow and dark pools point in different directions.
globaltradersacademy.com
November 11, 2026 at 12:53 PM
November 9, 2026 at 11:00 AM
November 9, 2026 at 5:02 PM
November 9, 2026 at 1:30 PM
$AXSM: Axsome's Q3 net product revenue rose 52% to $259.7M; AUVELITY sales grew 53% to $207.6M and the net loss narrowed to $12.9M. Not investment advice.

https://www.merlintrader.com/axsome-therapeutics-axsm-stock-hub-2026/
November 8, 2026 at 9:55 AM
$CRSP-1 $EZPW-1 $BTDR-1 $AXSM-1 $LSCC-1 $ANDE-1 $MARA-1 $MDB-1 $FLUT-1 $ASML-1 $GBTC-1 $TXG-1 $WDAY-1 $CHKP-1 $DJT-1 $KMPR-1 $AMD-1 $FLIN-1 $ASND-1 $AVGO-1 $SMCI-1 $APTV-1 $B-1 $NBIG-1 $IGV-1 $EFG-1

Daily Wrap - Final Message: Daily Wrap up for 2026-11-10 - 2475 events.

#burst_trades #HFT #trading
November 10, 2026 at 9:21 PM
#$AXSM — Axsome: Q3 revenue $259.7M, up 52% y/y; AUVELITY sales $207.6M (+53%).
GAAP net loss narrowed to $12.9M; cash $313.9M at Sep 30.

AXSM Stock Hub: Axsome Therapeutics News, AUVELITY and AXS-12
www.merlintrader.com/axsome-thera...
November 4, 2026 at 2:24 PM
Axsome #$AXSM lined up a busy November investor conference schedule.

Shares closed at $136.01 Mon: below SMA50, below SMA200, RSI 20 (oversold).

Hub: www.merlintrader.com/axsome-thera...

Not investment advice.
AXSM Stock: Axsome Therapeutics News, AUVELITY & AXS-12
Axsome Therapeutics stock news and analysis: revenue from three marketed medicines, AXS-12 review, ENGAGE data, cash use, debt and the key risks for AXSM.
www.merlintrader.com
November 3, 2026 at 4:09 PM
$AXSM Q3 revenue jumped 52% and the loss narrowed, shares now down 10.5% to $129.28 on 1.39M shares versus $144.43 prior close. Tapeboard scanner… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=axsm-bk-dn-scanner&utm_term=scanner&s=AXSM
November 2, 2026 at 4:46 PM
$AXSM Q3 EPS beat and sales beat printed overnight, session breakout fading hard now. Tapeboard flagged at $140.00, down 7% since the flag and givin… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=axsm-bk-dn-tape&utm_term=scanner&s=AXSM
November 2, 2026 at 2:45 PM
#$AXSM $131.83: below SMA50 ($183.24), below SMA200 ($199.11), RSI 18.

Falling despite Nov 2 Q3 results: net product revenue $259.7M (+52% y/y), AUVELITY sales $207.6M (+53%).

Bull/bear scenarios, S/R and trendlines on JC Just Charts: justcharts.merlintrader.com#AXSM

Not investment advice.
November 2, 2026 at 7:58 PM
www.stocktitan.net
November 2, 2026 at 12:00 PM
Axsome Therapeutics $AXSM reported Q3 2026 EPS of -$0.25, beating the -$0.64 estimate by 60.9%. Revenue of $259.7M beat the $248.6M estimate by 4.4%.

https://fundspec.ai/s/AXSM/earnings
Get a push the moment an analyst moves a price target.
November 2, 2026 at 12:06 PM
🚨 $AXSM
On November 2, 2026, Axsome Therapeutics, Inc. issued a press release announcing its financial results for the three months ended September 30, 2026, and provided an update on the Company’s operations.
SEC Filing: AXSM
Click to view the official SEC document.
www.sec.gov
November 2, 2026 at 12:06 PM
#$AXSM fell ~14% despite strong Q3 on no guidance, high costs, and slow Alzheimer’s launch questions. #$PGEN plunged ~26% after FDA approved Inovio’s rival drug for the same rare throat disease. #$TEVA dipped after stopping a small Phase 2 trial unlikely to succeed. notreload.xyz/wall-street-...
November 2, 2026 at 4:19 PM
#$AXSM weekly close $144.43 (-0.4% w/w), below SMA50 $184.76 / below SMA200 $199.33, RSI 24.3. Support $131.26, resistance $179.70.

New hub updated: www.merlintrader.com/axsome-thera...
AXSM Stock: Axsome Therapeutics News, AUVELITY & AXS-12
Axsome Therapeutics stock news: $218.4M Q2 revenue, $319.9M June cash, November 2results and a May 1, 2027 AXS-12 target action date.
www.merlintrader.com
October 31, 2026 at 7:27 AM
#$AXSM weekly close $144.43 (-0.4% w/w), below SMA50 $184.76 / below SMA200 $199.33, RSI 24.3. Support $131.26, resistance $179.70.

New hub updated: www.merlintrader.com/axsome-thera...
AXSM Stock: Axsome Therapeutics News, AUVELITY & AXS-12
Axsome Therapeutics stock news: $218.4M Q2 revenue, $319.9M June cash, November 2results and a May 1, 2027 AXS-12 target action date.
www.merlintrader.com
October 31, 2026 at 7:27 AM
$AXSM slipped 7.1% to $145.04 on Friday, below both the 50-day SMA ($191.84) and the 200-day ($195.57), near the bottom of its 20-day range. Daily RSI 22, oversold territory.
$SPY $XBI. Not investment advice.

Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#AXSM
October 26, 2026 at 10:30 AM
$AXSM breakout scanner flagged it earlier today, now down 7.2% to $144.90 on 1,065,866 shares vs $156.07 prior close. Tapeboard chart is up, scanner… https://tapeboard.com/go/bsky/research/AXSM?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=axsm-bk-dn-tape&utm_term=research
October 23, 2026 at 6:18 PM
$PROP-1 $GDXJ-1 $ZETA-1 $SMTC-1 $BMNR-1 $PTIR-1 $BWXT-1 $SPDN-1 $FHN-1 $NVDX-1 $TXN-1 $T-1 $AXSM-1 $U-1 $MDB-1 $BFH-1 $AEHR-1 $MAGS-1 $VECO-1 $QNT-1 $CRK-1 $CWH-1 $COF-1 $CVX-1 $XLE-1 $NWG-1 $KDP-1

Daily Wrap - Final Message: Daily Wrap up for 2026-10-15 - 2145 events.

#burst_trades #HFT #trading
October 15, 2026 at 8:37 PM
3rd Rail Alert Part 1 - 09/29/26 Top Unusual Implied Vol Stocks

#$ABCL #$ABUS #$ADBT #$ADGM #$ANVS #$ARM #$ASML #$AUID #$AXG #$AXSM #$AXTI #$AZ #$BCDA #$BE #$CDW #$CLLS #$CLPT #$CNXC #$CRCL #$CVNA #$CYPH #$DNA #$DPRO #$EIX #$ENVX #$FRVO #$GLW #$GRAL

www.patreon.com/posts/170976...
💎IV Change Details For 100+ Stocks
September 30, 2026 at 8:02 AM
Narcolepsy after the orexin approval: #$ALKS, #$AXSM, #$JAZZ and #$TAK
www.merlintrader.com/narcolepsy-o...
September 25, 2026 at 6:40 PM